Kirsten Axelsen argues that adopting foreign-style drug pricing models in the United States would harm patients and stifle innovation. While other nations keep prices low by denying access through health technology assessments and rigid cost-effectiveness thresholds, the U.S. system fosters competition, broad access, and generics that lower costs. She contends the U.S. should push for fairer global cost-sharing rather than importing restrictive foreign policies.
Tag: England
Posted inBooks
A Black author takes a new look at Georgia’s White founder and his failed attempt to ban slavery
By Russ Bynum, The Associated Press SAVANNAH, Ga. (AP) — Michael Thurmond thought he was reading familiar history at the burial place of Georgia’s colonial founder. Then a single sentence on a marble plaque extolling the accomplishments of James Edward Oglethorpe left him stunned speechless. Within a lengthy tribute to the Englishman who died in […]